WO2011150395A3 - Compositions à base de nutriments - Google Patents

Compositions à base de nutriments Download PDF

Info

Publication number
WO2011150395A3
WO2011150395A3 PCT/US2011/038442 US2011038442W WO2011150395A3 WO 2011150395 A3 WO2011150395 A3 WO 2011150395A3 US 2011038442 W US2011038442 W US 2011038442W WO 2011150395 A3 WO2011150395 A3 WO 2011150395A3
Authority
WO
WIPO (PCT)
Prior art keywords
compositions
preparations
nutrient compositions
nutritional mixture
isolated lactoferrin
Prior art date
Application number
PCT/US2011/038442
Other languages
English (en)
Other versions
WO2011150395A2 (fr
Inventor
Jeffrey L. Lillard
Rosalba Paesano
William A. Goolsbee
Piera Valenti
Miriam Pietropaoli
Original Assignee
Bmg Hematology Llc
Microbo S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bmg Hematology Llc, Microbo S.R.L. filed Critical Bmg Hematology Llc
Publication of WO2011150395A2 publication Critical patent/WO2011150395A2/fr
Publication of WO2011150395A3 publication Critical patent/WO2011150395A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention porte sur des préparations et sur des compositions qui comportent une lactoferrine isolée et un mélange nutritionnel et qui ne comprennent pas de source inorganique d'une quantité biologiquement efficace de fer. Dans des modes de réalisation particuliers, l'invention porte sur des préparations et sur des compositions qui comportent une lactoferrine isolée et un mélange nutritionnel comportant au moins de l'acide folique et de la vitamine B6 en quantités suffisantes pour compléter les exigences diététiques quotidiennes d'un adulte, y compris d'une femme enceinte, d'un nourrisson ou d'un enfant.
PCT/US2011/038442 2010-05-28 2011-05-27 Compositions à base de nutriments WO2011150395A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US34969810P 2010-05-28 2010-05-28
US61/349,698 2010-05-28
US42398310P 2010-12-16 2010-12-16
US61/423,983 2010-12-16

Publications (2)

Publication Number Publication Date
WO2011150395A2 WO2011150395A2 (fr) 2011-12-01
WO2011150395A3 true WO2011150395A3 (fr) 2012-04-26

Family

ID=45004885

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2011/038442 WO2011150395A2 (fr) 2010-05-28 2011-05-27 Compositions à base de nutriments

Country Status (1)

Country Link
WO (1) WO2011150395A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3566708T3 (pl) * 2012-05-14 2021-11-22 Warburton Technology Limited Roztwór pierwiastków śladowych
FR2994657A1 (fr) * 2012-08-23 2014-02-28 Henri Allain Nouvelles applications et utilisations de la lactoferrine
EP3294072A4 (fr) * 2015-05-15 2019-03-13 The Johns Hopkins University Nouveau complément alimentaire prénatal de fluorure
IT201600128713A1 (it) * 2016-12-20 2018-06-20 Frima Res Srls Composizione nel trattamento dell'anemia infiammatoria o da flogosi da malattia cronica
US20180181718A1 (en) * 2016-12-23 2018-06-28 King Abdulaziz University Interactive clinical decision support system
US20200024329A1 (en) 2018-07-17 2020-01-23 Bradley G. Thompson Methods for regulating endogenous production of lactoferrin and sub-peptides thereof
EP4065146A1 (fr) * 2019-11-29 2022-10-05 Société des Produits Nestlé S.A. Compositions et procédés avec un probiotique et un nutriment et/ou un minéral pour la prévention ou le traitement de la mastite

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
NAPPI, C. ET AL.: "Efficacy and tolerability of oral bovine lactoferrin compared to ferrous sulfate in pregnant women with iron deficiency anemia: a prospective controlled randomized study", ACTA OBSTET GYNECOL SCAND, vol. 888, no. 9, 2009, pages 1031 - 1035 *
PAESANO, R. ET AL.: "Oral administration of lactoferrin increases hemoglobin and total serum iron in pregnant women", BIOCHEM CELL BIOL., vol. 84, no. 3, 2006, pages 377 - 380 *
PAESANO, R. ET AL.: "The influence of lactoferrin, orally administered, on systemic iron homeostasis in pregnant women suffering of iron deficiency and iron deficiency anaemia", BIOCHIMIE., vol. 91, no. ISSUE, January 2009 (2009-01-01), pages 44 - 51 *
PICCIANO, M.: "Pregnancy and Lactation: Physiological Adjustments, Nutritional Requirements and the Role of Dietary Supplements", THE JOURNAL OF NUTRITION, vol. 133, 2003, pages 1997S - 2002S *

Also Published As

Publication number Publication date
WO2011150395A2 (fr) 2011-12-01

Similar Documents

Publication Publication Date Title
WO2011150395A3 (fr) Compositions à base de nutriments
MX2012001269A (es) Composiciones nutricionales que contienen fibra y probioticos.
MY191538A (en) Human milk oligosaccharides to promote growth of beneficial bacteria
NZ631085A (en) Infant formula milk powder and preparation method thereof
WO2007092451A3 (fr) Polysaccharides zwitterioniques pour favoriser la maturation du système immunitaire et la santé
WO2009037562A3 (fr) Formulations de suppléments nutritifs destinées à être incorporées dans des aliments et aliments enrichis comprenant de tels suppléments
WO2011106423A3 (fr) Formulations à base d'acai et d'iridoïdes
MY175195A (en) Nutritional compositions
WO2011106448A3 (fr) Formulations à base d'iridoïdes
MX2014014338A (es) Suplemento proteinico liquido esterilizado que incluye proteina nutricional con solubilidad mejorada.
JP2010275318A5 (fr)
MX2012010487A (es) Composicion de nutrimientos y sustancias bioactivas que favorecen el crecimiento y que disminuyen la intolerancia y los efectos adversos en infantes prematuros.
WO2009118771A3 (fr) Utilisation de lactoferrine pour la prévention de sepsies néonatales chez des nouveaux-nés prématurés
GB201310235D0 (en) Nutraceutical and pharmaceutical composition
MX2011007222A (es) Composicion nutricional para infantes.
WO2012120462A3 (fr) Supplémentation orale pour l'inversion de la canitie des cheveux
AU2011343331A8 (en) Compositions based on clay and bee pollen, method for preparing same, and nutritional and therapeutic uses thereof
CN105124377A (zh) 一种保健米粉
EP4233908A3 (fr) Compositions nutritionnelles et préparations pour nourrissons permettant de favoriser la myélinisation dans le cerveau
TW200640379A (en) Gamma-polyglutamic acid (gamma-PGA, H form) and gamma-polyglutamates for use as nutrition supplements in dietary products
PE20141022A1 (es) Composiciones y procedimientos para la administracion de nutrientes
SI2016838T1 (en) Food supplement
CN104223093A (zh) 一种食品复合营养强化剂
WO2008128761A3 (fr) Maïs à haute teneur en pigments et a teneur réduite en mycotoxines, sa préparation et son utilisation
Yu et al. The effects on children's growth, hemoglobin concentration, and anemia in 3 nutrition interventions in poor rural, China

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11787542

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11787542

Country of ref document: EP

Kind code of ref document: A2